Spectral Ai, Inc. MDAI

FY2025 · ended Dec 31, 2025 · Revenue $19.65M, -33.6% YoY · Filed Mar 25, 2026

Spectral Ai, Inc. (MDAI) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $19.6 million and a net loss of $7.6 million. As of Jun 30, 2026 it held $14.0 million in cash and investments and $13.2 million in total debt.

Revenue (TTM)
$15.39M
-44.1% vs year-ago TTM
Net income (TTM)
$-10.09M
+28.8% vs year-ago TTM
Operating cash flow (TTM)
$-12.88M
-113.8% vs year-ago TTM
Free cash flow
—
EPS (TTM)
$-0.33
+49.2% vs year-ago TTM
Dividend per share
None
Shares outstanding
31.82M
+25.7% vs prior year
Net cash
$845,000
as of Jun 30, 2026
Operating margin
-77.2%
FY 2026

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
MDAI (Nasdaq), MDAIW (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Dallas, TX
SEC filer status
, Emerging growth company
SEC CIK
1833498
Former names
Rosecliff Acquisition Corp I (until Sep 13, 2023)

Other Surgical & Medical Instruments & Apparatus companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

Line
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
Revenue
$19.6M
$29.6M
$18.1M
—
—
Operating income
-$8.6M
-$6.6M
-$13.0M
-$2.6M
-$3.4M
Net income
-$7.6M
-$15.2M
-$20.9M
-$2.9M
-$2.1M
Diluted EPS
-$0.29
-$0.85
-$1.48
—
—
Operating cash flow
-$9.9M
-$9.2M
-$13.2M
-$1.2M
-$825,593
Total assets
$21.4M
$12.1M
$10.7M
$18.7M
$254.1M
Total liabilities
$27.1M
$19.3M
$12.4M
$6.7M
$21.9M
Stockholders' equity
-$5.7M
-$7.3M
-$2.1M
$12.0M
$13.8M
Cash and investments
$15.4M
$5.2M
$4.8M
$14.2M
$253.8M
Total debt
$11.0M
$1.9M
$853,000
$346,000
—

Recent SEC filings

Recent SEC filings
Form Description Filed Period
8-K Current report
Regulation FD disclosure
Sep 15, 2026 Sep 14, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Aug 12, 2026 Aug 11, 2026
10-Q Quarterly report Aug 11, 2026 Jun 30, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Jul 8, 2026 Jul 7, 2026
8-K Current report
Shareholder vote results, Regulation FD disclosure
Jun 1, 2026 May 29, 2026
8-K Current report
Regulation FD disclosure
May 26, 2026 May 26, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.